Process for the preparation of 3-amino-pyrrolidine derivatives
    79.
    发明公开
    Process for the preparation of 3-amino-pyrrolidine derivatives 审中-公开
    Verfahren zur Herstellung von 3-Aminopyrrolidinderivaten

    公开(公告)号:EP1138672A1

    公开(公告)日:2001-10-04

    申请号:EP01114294.0

    申请日:1999-01-08

    IPC分类号: C07D207/14

    摘要: The invention is concerned with a process for the manufacture of 3-amino-pyrrolidine derivatives of the formula
       wherein

    R 1 signifies hydrogen, alkyl, cyclo-alkyl, alkenyl, aryl or an amino protecting group; and
    R 2 , R 3 each independently signify hydrogen, alkyl, cyclo-alkyl, alkenyl or aryl;
    by converting a compound of the formula
    wherein

    X signifies a protected hydroxy group;
    in the presence of a primary amine of the formula R 1 NH 2 into the pyrrolidine derivative of the formula
       wherein X and R 1 have the aforementioned significances;
    which is subsequently reacted in the presence of R 2 R 3 NH under pressure.

    摘要翻译: 本发明涉及制备式CHEM的3-氨基 - 吡咯烷衍生物的方法,其中R 1表示氢,烷基,环烷基,烯基,芳基或氨基保护基; R 2,R 3各自独立地表示氢,烷基,环烷基,烯基或芳基; 通过转化式的化合物,其中X表示被保护的羟基; 在式R 1 NH 2的伯胺存在下进入式CHEM的吡咯烷衍生物,其中X和R 1具有上述含义; 其随后在R 2 R 3 NH的存在下在压力下反应。

    ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES
    80.
    发明公开
    ACETAMIDE AND SUBSTITUTED ACETAMIDE-CONTAINING THIOUREA INHIBITORS OF HERPES VIRUSES 审中-公开
    乙酰胺和取代的乙酰胺含硫脲ALS抑制剂疱疹病毒

    公开(公告)号:EP1137633A2

    公开(公告)日:2001-10-04

    申请号:EP99965132.6

    申请日:1999-12-06

    摘要: Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; G is alkyl of 1 to 6 carbon atoms; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or pharmaceutical salts thereof, are useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.